Neuralis is rated 3 out of 5 in the category medical devices. Read and write reviews about Neuralis. Neuralis’ vision is to save and improve lives, for which our application LiNN is our launching pad. Using machine learning, LiNN is able to reliably estimate the risk for suicide attempts and self-harming actions in bipolar patients. LiNN is able to more accurately assess this risk than existing rating scales currently used by doctors. As such, LiNN could potentially reduce the number of suicides among these patients, who have a significantly elevated risk of committing suicide.
Company size
1-10 employees
Headquarters
Gothenburg, VG